Tag Archives: NASDAQ:OPHT

Cowen & Co. Downgrades Ophthotech Corp to Hold

Cowen & Co. analyst Tyler Van Buren downgraded Ophthotech Corp (NASDAQ: OPHT) to Hold today. The company’s shares opened today at $6.23, close to its 52-week low of $5.65. According to TipRanks.com, Buren is a 1-star analyst with an average

Ophthotech Corp was Downgraded to a Hold Rating at Barclays

In a report released today, Geoff Meacham from Barclays downgraded Ophthotech Corp (NASDAQ: OPHT) to Hold. The company’s shares opened today at $6.23, close to its 52-week low of $5.65. According to TipRanks.com, Meacham is a 5-star analyst with an

Barclays Thinks Ophthotech Corp’s Stock is Going to Recover

In a report released yesterday, Geoff Meacham from Barclays reiterated a Buy rating on Ophthotech Corp (NASDAQ: OPHT), with a price target of $70. The company’s shares opened today at $35.25, close to its 52-week low of $29.85. Meacham wrote:

Analysts Offer Insights on Healthcare Companies: Ophthotech Corp (NASDAQ: OPHT) and Iradimed Corp (NASDAQ: IRMD)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ophthotech Corp (NASDAQ: OPHT) and Iradimed Corp (NASDAQ: IRMD). Ophthotech Corp (NASDAQ: OPHT) Chardan Capital analyst Gbola Amusa reiterated a Buy rating on